History, clinical presentation, therapy, and patient reported outcomes of mucosal lichen planus: a cross‐sectional study
JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2025
DOI: 10.1111/ddg.15610 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2025. Verfasst von Neda Cramer und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany. Hauptthemen laut MEDLINE: Glucocorticoids, Lichen Planus, Lichen Planus, Oral. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Objectives Mucosal lichen planus (LP) is a chronic inflammatory disease. The patient's journey can be arduous as diagnosis and therapy are challenging. Patients and Methods In this cross‐sectional study, a wide range of characteristics of the patient's journey were assessed and evaluated from a total of 72 patients with mucosal LP who were treated in the dermatology departments of six German university medical centers between 02/2022 and 07/2023.
Results
On average, 18.1 months elapsed between the onset of symptoms and diagnosis. Until the correct diagnosis was made, an average of 3.1 different physicians of the same or different specialties were consulted. 28.1% of patients also had cutaneous involvement. Therapeutically, 68% of patients received at least one systemic drug. Both topical (90%, 65/72) and systemic (oral, 50% of patients, 36/72; intravenous, 33%, 24/72) glucocorticoids were most frequently used. Systemic agents were most often discontinued due to ineffectiveness (46%, 50/110). Satisfaction with treatment was highest for intravenous and topical glucocorticoids (moderate to high satisfaction: 59% and 36%, respectively), and lowest for retinoids with 8%.
Conclusions
This study indicates that there might be a lack of diagnostic awareness among physicians and the unmet need for effective systemic treatment options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany.
- Cytel Inc., Berlin, Germany.
- Department of Dermatology, Technische Universität Dresden, University Hospital, Dresden, Germany.
- Department of Oral and Maxillofacial Surgery, University Medical Centre Göttingen, Göttingen, Germany.
- Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany.
- Department of Dermatology, Venereology and Allergology, University Hospital Essen, Essen, Germany.
ORCID-Profile: Neda Cramer, Katharina Assaf, Matthias Goebeler, Dagmar Wilsmann-Theis, Claudia Günther, Christian Kromer, Rotraut Mössner
Zitieren
APA
Cramer, N., Kromer, D., Bootsveld, J. M., Sennhenn-Kirchner, S., Gerdes, S., Sondermann, W., Assaf, K., Goebeler, M., Wilsmann-Theis, D., Günther, C., Kromer, C., & Mössner, R. (2025). History, clinical presentation, therapy, and patient reported outcomes of mucosal lichen planus: a cross‐sectional study. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.15610
Vancouver
Cramer N, Kromer D, Bootsveld JM, Sennhenn-Kirchner S, Gerdes S, Sondermann W, et al. History, clinical presentation, therapy, and patient reported outcomes of mucosal lichen planus: a cross‐sectional study. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2025. doi:10.1111/ddg.15610
BibTeX
@article{Cramer2025,
author = {Cramer, Neda and Kromer, Daniel and Bootsveld, Julia M and Sennhenn-Kirchner, Sabine and Gerdes, Sascha and Sondermann, Wiebke and Assaf, Katharina and Goebeler, Matthias and Wilsmann-Theis, Dagmar and Günther, Claudia and Kromer, Christian and Mössner, Rotraut},
title = {History, clinical presentation, therapy, and patient reported outcomes of mucosal lichen planus: a cross‐sectional study},
journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
year = {2025},
doi = {10.1111/ddg.15610}
}
EUVIMED